Tag: Novo Nordisk

Novo Nordisk maintains a complete R&D industry chain in China

Novo Nordisk China announced the launch of the China Essentials program — the guidelines to integrate China into Novo Nordisk's global clinical development program and achieve simultaneous submission ...

Novo Nordisk Offers Free 90-day Insulin Supply to People Affected by COVID-19

Novo Nordisk is expanding its popular free insulin access program to include workers affected by COVID-19. People with diabetes using Novo Nordisk Inc. insulin who have lost health insurance coverage...

Novo Nordisk Invests DKK 800 Million in Upgrading and Expanding Production Facilities in Denmark

Novo Nordisk announced plans to invest DKK 800 million in upgrading and expanding facilities at its production site in Kalundborg, Denmark. The facilities currently manufacture a range of products ...

HighRes Biosolutions and Novo Nordisk Will Collaborate to Design a State-of-the-art Robotic Platform...

HighRes Biosolutions and Novo Nordisk announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation. The integrat...

FDA Has Approved a New Indication for Ozempic® (semaglutide)

Novo Nordisk Jan. 16 announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Ozempic® (semaglutide) injection 0.5 mg or 1 mg to reduce the risk of major adverse ca...

UVA Center for Diabetes Technology and Novo Nordisk Entered Five-Year Research Collaboration

novo nordisk
University of Virginia (UVA) Center for Diabetes Technology and Novo Nordisk announced that they have entered into a five-year research collaboration where UVA and Novo Nordisk will work together on t...

Semaglutide as Add-On Therapy Proved to be Effective for Type 2 Diabetes Treatment

novo nordisk
The Institute for Clinical and Economic Review (ICER) released an Evidence Report assessing the comparative clinical effectiveness and value of oral semaglutide (Rybelsus® Novo Nordisk), a GLP-1 recep...

Novo Nordisk and UNICEF Announced Partnership to Prevent Childhood Overweight and Obesity

novo nordisk
Novo Nordisk and UNICEF announced a new partnership to help prevent childhood overweight and obesity worldwide with an initial focus on interventions in Latin America and the Caribbean. Under this ...

Dicerna™ and Novo Nordisk Agreed to Develop Therapies for Liver-Related Cardio-Metabolic Diseases

Novo Nordisk
Dicerna™ Pharmaceuticals, Inc. and Novo Nordisk A/S announced an agreement to discover and develop novel therapies for the treatment of liver-related cardio-metabolic diseases using Dicerna’s propriet...

Novo Nordisk Obtained Exclusive Worldwide License to UBE’s Preclinical Asset UD-014

Novo Nordisk A/S and UBE Industries Ltd. announced that Novo Nordisk has obtained an exclusive worldwide license to UBE’s preclinical asset UD-014, a selective Semicarbazide-Sensitive Amine Oxidase/Va...

Novo Nordisk Operating Profit Increased by 11%

novo nordisk
Novo Nordisk's operating profit increased by 11% in Danish kroner and by 5% at constant exchange rates (CER) in the first nine months of 2019. Sales increased by 9% in Danish kroner and by 5% at ...

bluebird bio and Novo Nordisk to Develop in Vivo Genome Editing Treatments for Genetic Diseases

Novo Nordisk
bluebird bio, Inc. and Novo Nordisk announced that they have entered into a three-year research collaboration to jointly develop next-generation in vivo genome editing treatments for genetic diseases,...

Novo Nordisk and Noom Announced Collaboration on Digital Health Solutions

novo nordisk
Novo Nordisk, a global healthcare company, and Noom, a leading behaviour change company, announced a collaboration on digital health solutions focusing on weight management and education, with the aim...

Novo Nordisk Rybelsus Approved by FDA

The U.S. Food and Drug Administration approved Rybelsus (semaglutide) oral tablets to improve control of blood sugar in adult patients with type 2 diabetes, along with diet and exercise. Rybelsus is t...

Medtronic and Novo Nordisk Announced Collaboration Agreement

Medtronic plc and Novo Nordisk A/S announced a collaboration that will develop solutions to integrate insulin dosing data from future Novo Nordisk smart insulin pens into Continuous Glucose Monitoring...

Novo Nordisk to Offer Cheaper Insulin to U.S. Diabetics

novo nordisk
Novo Nordisk will offer cheaper insulin to U.S. diabetics, the Danish drugmaker said on Friday, in response to criticism over the high price of the medication and after similar moves by rivals Sanofi ...